Recruiting
Phase 1
Phase 2

Ceftriaxone

Sponsor:

Hackensack Meridian Health

Code:

NCT06785402

Conditions

Post-Treatment Lyme Disease Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ceftriaxone treatment

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-03. This information was provided to ClinicalTrials.gov by Hackensack Meridian Health on 2025-10-31.